Amanote Research
Register
Sign In
P3.04-17 Cost-Effectiveness of Atezolizumab for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) in Canada
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.08.1724
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
October 1, 2018
Authors
U. Ondhia
H. Conter
S. Owen
A. Zhou
J. Nam
S. Singh
A. Abdulla
P. Chu
F. Felizzi
R. Sangha
Publisher
Elsevier BV
Related search
Pcn176 - A Cost-Effectiveness Analysis of Atezolizumab Versus Docetaxel for Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer in Belgium
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Comparative Efficacy of Treatments for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer (Nsclc): A Network Meta-Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Effectiveness of First-Line Therapy for Advanced Non-Small Cell Lung Cancer (Nsclc)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pcn148 - Cost-Effectiveness Analysis of Atezolizumab Compared to Treatment Options for Adult Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (Nsclc) After Prior Chemotherapy - Updated Results
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
A Systematic Review of the Cost-Effectiveness of Targeted Therapies for Metastatic Non-Small Cell Lung Cancer (NSCLC)
BMC Pulmonary Medicine
Pulmonary
Respiratory Medicine
Pcn4 - Effectiveness and Safety of Pembrolizumab in Advanced or Metastatic Non-Small Cell Lung Cancer
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Effectiveness Analysis of Pembrolizumab Plus Chemotherapy for Previously Untreated Metastatic Non-Small Cell Lung Cancer in the USA
BMJ Open
Medicine
Phase II Study of S-1 and Docetaxel for Previously Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Atezolizumab in Japanese Patients With Previously Treated, Advanced Non–small-Cell Lung Cancer: A Subgroup Analysis of the Phase 3 OAK Study
Clinical Lung Cancer
Cancer Research
Oncology
Respiratory Medicine
Pulmonary
